-- Sanofi Lixisenatide Treatment Had Significant Phase 3 Results
-- B y   D a v i d   W h i t e h o u s e
-- 2010-09-30T05:07:17Z
-- http://www.bloomberg.com/news/2010-09-30/sanofi-lixisenatide-treatment-had-significant-phase-3-results.html
Sanofi-Aventis SA said that a phase
three study in which lixisenatide was combined with basal
insulin achieved significant results and may lead to a new
glucose-control treatment in diabetes patients.  The company published the results in an emailed statement.  To contact the editor responsible for this story:
David Whitehouse at 
 dwhitehouse1@bloomberg.net  